CorMedix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	48.49	40.65	43.64	43.15	53.32	41.91
Short-Term Investments	7.22	11.04	32.39	15.64	12.15	4.44
Cash & Short-Term Investments	55.72	51.69	76.03	58.79	65.47	46.35
Cash Growth	21.04%	-32.02%	29.32%	-10.20%	41.24%	63.58%
Receivables	158.57	51.65	-	-	0.05	0
Inventory	28.92	7.6	2.11	-	0	0.14
Prepaid Expenses	13.93	3.39	0.76	0.62	0.77	1.41
Restricted Cash	-	-	0.08	0.12	0.13	0.19
Other Current Assets	2.4	0.24	0.47	0.01	0.05	0.08
Total Current Assets	259.54	114.58	79.45	59.55	66.47	48.18
Property, Plant & Equipment	8.39	2.32	2.51	2.38	2.37	1.13
Other Intangible Assets	390.01	1.84	-	-	-	-
Other Long-Term Assets	22.91	0.11	0.1	0.1	0.1	-
Total Assets	750.86	118.85	82.06	62.04	68.95	49.31
Accounts Payable	20.45	1.72	4.28	2.2	2.21	1.13
Accrued Expenses	103.26	29.95	6.97	3.97	3.01	2.92
Current Portion of Leases	1.42	0.17	0.15	0.13	0.12	0.11
Current Income Taxes Payable	4.22	-	-	-	-	-
Other Current Liabilities	4.28	2	-	-	-	-
Total Current Liabilities	133.64	33.84	11.4	6.31	5.35	4.16
Long-Term Debt	144.53	-	-	-	-	-
Long-Term Leases	2.97	0.35	0.52	0.67	0.8	0.92
Total Liabilities	376.73	34.19	11.92	6.98	6.15	5.09
Common Stock	0.08	0.06	0.05	0.04	0.04	0.03
Additional Paid-In Capital	564.56	424.13	391.69	330.29	308.33	261.54
Retained Earnings	-190.6	-339.63	-321.7	-275.36	-245.66	-217.45
Comprehensive Income & Other	0.09	0.09	0.09	0.08	0.09	0.1
Total Common Equity	374.13	84.66	70.14	55.06	62.8	44.22
Shareholders' Equity	374.13	84.66	70.14	55.06	62.8	44.22
Total Liabilities & Equity	750.86	118.85	82.06	62.04	68.95	49.31
Total Debt	148.92	0.52	0.67	0.8	0.92	1.03
Net Cash (Debt)	-93.2	51.17	75.36	57.99	64.54	45.32
Net Cash Growth	-	-32.10%	29.96%	-10.15%	42.43%	59.96%
Net Cash Per Share	-1.29	0.87	1.48	1.44	1.71	1.59
Filing Date Shares Outstanding	78.79	65.18	54.98	44.48	38.71	38
Total Common Shares Outstanding	78.35	64.41	54.94	42.79	38.06	33.54
Working Capital	125.89	80.74	68.05	53.24	61.12	44.02
Book Value Per Share	4.78	1.31	1.28	1.29	1.65	1.32
Tangible Book Value	-33.4	82.81	70.14	55.06	62.8	44.22
Tangible Book Value Per Share	-0.43	1.29	1.28	1.29	1.65	1.32

Updated Nov 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q